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Background: Fibromyalgia patients are often advised to engage in regular low- to moderate-intensity physical
exercise. The need of fibromyalgia patients to walk has been stressed in previous research. Behavioral self-regulation
theories suggest that a combination of motivational aspects (to develop or strengthen a behavioral intention:
Theory of Planned Behavior) and volitional aspects (engagement of intention in behavior: implementation
intentions) is more effective than a single intervention. In this paper, we describe a protocol for identifying the
motivational processes (using the Theory of Planned Behavior) involved in the practice of walking (phase I) and for
studying the efficacy of an intervention that combines motivational and volitional contents to enhance the
acquisition and continuation of this exercise behavior (phase II). The paper also shows the characteristics of eligible
individuals (women who do not walk) and ineligible populations (women who walk or do not walk because of
comorbidity without medical recommendation to walk). Both groups consist of members of any of four patients’
associations in Spain who are between 18 and 70 years of age and meet the London Fibromyalgia Epidemiology
Study Screening Questionnaire criteria for fibromyalgia. Furthermore, using this study protocol, we will explore the
characteristics of participants (eligible women who agreed to participate in the study) and nonparticipants (eligible
women who refused to participate).
Methods/design: Two studies will be conducted: Phase I will be a cross-sectional study, and phase II will be a
triple-blind, randomized longitudinal study with two treatment groups and one active control group. The
questionnaires were sent to a total of 2,227 members of four patients’ associations in Spain. A total of 920
participants with fibromyalgia returned the questionnaires, and 582 were ultimately selected to participate.
Discussion: The first data gathered have allowed us to identify the characteristics of the study population and they
support the appropriateness of the inclusion criteria.. When the study is complete, the results will enable us to
establish whether this kind of intervention can be used as a self-regulation tool for increasing and maintaining
walking as unsupervised physical exercise of low to moderate intensity in fibromyalgia patients.
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Fibromyalgia (FM) is a complex chronic condition char-
acterized by widespread musculoskeletal pain, fatigue,
sleeping problems and other symptoms with no well-
established etiology. Physical exercise is a component of
effective treatment [1], and aerobic exercise in particular
has been shown to lead to improvements in various
health outcomes [2-7]. To the best of our knowledge,
most studies conducted to date have included supervised
physical exercise programs, which are often associated
with low patient adherence [8-12]. In fact, one of the
main challenges in FM treatment is achieving long-term
adherence to maintain the positive effects of physical ex-
ercise on patients’ health [10,13]. Some authors have
suggested that adherence represents a main issue and
should be a mandatory focus in studies of physical exer-
cise [6]. Walking is a low- to moderate-intensity exercise
which has been shown to have positive effects on FM
patients’ health status [4,14,15] and is a well-established
aerobic activity for these patients [10]. It is also a simple
recommendation that promotes patients’ self-management.
Any behavior, such as walking, is more likely to be
practiced if people are motivated and develop strategies
to engage in it. In the general population, combining
motivational and volitional interventions to increase
physical exercise or walking are more effective than initi-
ating and promoting each of them separately [16-20].
Motivational intervention encourages individuals to
form an intention, and volitional intervention encour-
ages them to form a plan stating when, where and how
they will carry out their intention (implementation in-
tentions). In FM patients, however, this combination has
not been tested. It is important to examine this issue in
this population because the presence of symptoms such
as pain and fatigue, which are associated with FM, could
affect walking behavior. Furthermore, these symptoms
may influence both motivational and volitional processes
for starting and maintaining walking behavior in FM pa-
tients, which is not the case in the general population.
Recently, Ang et al. [21] applied an intervention using
motivational interviewing to increase supervised walking
in FM patients. As these authors underlined, this strategy
is not based on any specific theory of health behavioral
change. In spite of the good results in the short-term, they
concluded that motivational interviewing alone is insuffi-
cient to increase physical activity in the long term. These
results support the importance of using volitional strat-
egies as well as basing the intervention on well-established
theories of health behaviors.
The Theory of Planned Behavior (TPB) [22-24] is a
well-established theory in health behavior and has been
shown to have predictive power regarding walking and
physical exercise [25,26]. In FM patients, TPB constructs
(see the “Interventions” subsection below) explained32% of the variance in the intention to exercise [27].
However, a strong behavioral intention is necessary, but
not sufficient, to implement action. The implementation
intentions are a theoretical proposal that focuses on the
gap between intention and action [28]. Implementation
intentions are specific plans that enhance the transition
of goal intentions into actions. Motivation is the starting
point for behavioral change and volitional strategies,
based on implementation intentions, to increase the like-
lihood of this change [18]. Once the behavior is started,
the processes associated with implementation intentions
(automatic activation of the behavior when environmental
cues are present) are expected to promote maintenance of
the behavior because it neither consumes cognitive re-
sources nor produces ego depletion as other self-regulation
processes do. Moreover, we expect that the benefits on
health status associated with walking behavior will also
promote its maintenance in the long term. In other popula-
tions and behaviors, the implementation intentions ap-
proach has produced better long-term behavioral change
[29]. Thus, we expect to find similar effects in our FM
population.
Applying both theories to promote behavioral change in
FM is expected to allow us to cover two basic processes:
(1) the adoption or strengthening of behavioral intentions
(motivational process) and (2) their effects on behaviors
(volitional or postmotivational process). In the FM con-
text, some special features, such as pain, health status im-
pact and fear of movement, should also be considered
[30]. These factors can influence both the intention to ex-
ercise and the exercise behavior itself. In fact, some factors
have been observed to be barriers to walking (MAP, SLR,
YS, CP, LV, MC, AL and CE, unpublished manuscript).
Not taking these factors into account has been considered
a limitation of previous studies [21].
To increase walking as unsupervised physical exercise, it
is important to test whether an intervention which in-
cludes motivational strategies (intentions) and volitional
strategies (implementation intentions) will be effective.
This paper describes the two phases of a protocol. In
phase I, we will identify the motivational processes in-
volved in intentions of performing a recommended walk-
ing pattern in FM patients, using the TPB and considering
the above-mentioned specific FM factors. In phase II, to
establish the efficacy of an intervention that combines
both motivational processes (based on the results of phase
I) and volitional processes to enhance the short-, medium-
and long-term adherence to a walking program.
This paper also describes the characteristics of eligible
populations (women belonging to FM associations, be-
tween 18 and 70 years of age, meeting the London
Fibromyalgia Epidemiology Study Screening Question-
naire criteria (London-4) (see http://www.aafplearnin
glink.org/Resources/Upload/File/AAFP-10-106-London%
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and noneligible populations (same characteristics men-
tioned above, but either able to walk or do not walk be-
cause of comorbidity without medical recommendation
for walking). This aim is needed to test the similarities be-
tween both populations in order to ensure the external
validity of the study. We will also explore the characteris-
tics of participants (women from the eligible population
who agreed to participate in the study) and nonpartici-
pants (women who refused to participate).Methods/design
This study has been approved by the Research Ethics
Board of the Miguel Hernández University, and we ob-
tained informed consent from each participant. Further-
more, participants signed a commitment of confidentiality
regarding the content of the assigned treatment.Description of the overall project
The study consists of two phases, both based on the
same population.
Phase I, conducted over the course of 1 year, is a
cross-sectional study with two measurement stages and
the following three aims:
1. We will seek to gain access to the reference
population, identify the eligible population, select the
study population and identify the prevalence of our
selected walking criteria (stage 1). The results of
stage 1 are included in this paper.
2. We will seek to identify the predictors of the
behavioral intention to carry out the selected
walking program using the TPB and exploring the
role of pain, impact of FM and fear of movement
(stage 2).
3. We will seek to explore the concordance of walking
behavior measurements (subjective and objective
measures) (stage 2).
Phase II, which will be conducted over the course of
2 years, is an experimental, randomized, triple-blind study
with two treatment groups and one active control group.
Longitudinal measures will be taken at baseline and at
7 weeks, 3 months and 9 months of postexperimental
intervention. One group will receive a motivational plus
implementation intentions intervention (MIG), a second
group will receive only an implementation intention inter-
vention (IG) and the control group (CG) will be given a
neutral task related to postural hygiene. The three groups
will receive the same information on the benefits of phys-
ical exercise in FM. Motivational intervention will be
based on the predictors of behavioral intention as mea-
sured and identified in phase I (stage 2) in order to createor strengthen the behavioral intention during the experi-
mental study.
This triple-blind study includes masking of the following
groups in the manner described. Participants will know
only that there are different intervention sessions but will
not know the session contents; moreover, they will be un-
aware of the assumptions regarding the superiority of one
intervention over another. Measures will be taken by re-
searchers who do not participate in the treatment applica-
tion and who are blinded to the experimental conditions.
The statistician will also be blinded to the study protocol.
The researchers who apply implementation intentions will
also be blinded with respect to the MIG or IG experimen-
tal condition. In this phase, we aim to study the efficacy of
the MIG intervention on unsupervised walking over the
short term (7 weeks), medium term (3 months) and long
term (9 months). The measurement at 7 weeks will be
taken during the week after completion of the 6-week
minimum walking program. We will base the selection of
the medium- and long-term measurements on the as-
sumption that the highest percentage of dropouts occurs
between 3 and 6 months in supervised physical exercise
programs [8,9]. On the day of the intervention, a re-
searcher will be responsible for the distribution of the
participants into the three different treatment groups fol-
lowing random assignment. The researcher will remind
participants of their confidentiality commitment.
Our main hypothesis is that a combined intervention
(both motivational and volitional) will significantly in-
crease walking behavior in comparison to the control
group and that this effect will be higher than that in a
merely volitional intervention in the short term and
stable in the medium and long term.
Our selected walking pattern for FM patients is between
two and four times weekly for about 50 minutes in bouts
of 15 to 20 minutes, with a small rest between bouts to
allow patients to avoid fatigue and continue the activity,
for a minimum of six consecutive weeks [31]. We chose
this pattern because it includes several components which
will encourage FM patients to do unsupervised physical
exercise. Walking is an accessible, cheap and flexible activ-
ity; it includes resting; and it requires minimal time, which
aids habit acquisition. Although we selected this pattern,
we reduced the minimum daily time to 30 minutes (in two
bouts of 15 minutes each) and at least two times weekly
because our target population is sedentary. In addition, pa-
tients will be advised to start physical exercise gradually
[10,11], beginning with a low, comfortable intensity ac-
cording to differences in physical capacity [4]. It is well
known that FM patients can benefit from low-intensity
walking programs 2 or 3 days per week [32]. Moreover,
30 minutes of continued physical activity has also been
shown to have positive effects on health in the general
population [33].
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The fibromyalgia associations of Alicante (ADEFA), Elche
(AFEFE), Madrid (AFIBROM) and Talavera de la Reina
(AFIBROTAR) collectively comprise a total of 2,438 mem-
bers with a clinical diagnosis of FM (75.8% diagnosed by
rheumatologists, 9.2% by general practitioners, 5.3% by
traumatologists, 2.2% by clinical rehabilitation specialists,
0.7% by neurologists and 6.7% by clinicians in other spe-
cialties). Slightly more than half (51.4%) of the sample are
receiving psychological treatment because of FM. To se-
lect our reference population (women between 18 and
70 years of age who meet the London Fibromyalgia
Epidemiology Study Screening Questionnaire criteria for
fibromyalgia (London-4) ), we first used the associations’
records to select the members who met the two first
criteria (n = 2,227). We then sent letters to these 2,227
women with information about the study, together with
informed consent forms, the London Fibromyalgia Epi-
demiology Study Screening Questionnaire [34,35] and
other questionnaires covering the remaining variables re-
lated to the sample characteristics and participationPHASE 1.  PATIENTS’ ASSOCIATIONS
INCLUSION CRITERIA:
WOMEN Excluded: ADEFA 2, AF
AGE [18, 69] Excluded: ADEFA 3, AF
LETTER
No response (N = 12
Response   
INCLUSION CRITERIA: Excluded (no data): N= 8
(London-4) Excluded: N= 44  (4.53%
REFERENCE POPULATION
INCLUSION CRITERIA: 
- DO NOT WALK  Excluded (Walk): N= 28
- IF HEALTH PROBLEMS: Excluded (Do not walkin
MEDICAL  N= 55 (5.98%)
RECOMMENDATION
ELIGIBLE POPULATION
Refused: N = 122 (21.0%




CONTROL GROUP IMPLEMENTATION INTE
N= 154 N= 153
N= 2438. ADEFA (N= 69),  AFEFE (
N= 2227. ADEFA (N= 64),  A
N= 972. ADEFA (N=46),  
N= 920. ADEFA (N=46), AFE
N= 582. ADEFA (N= 33),
N= 449. ADEFA (N= 25),
Figure 1 Flowchart of the participant recruitment process. ADEFA: Fib
Elche; AFIBROM: Fibromyalgia Association of Madrid; AFIBROTAR: Fibromyal
Fibromyalgia Epidemiology Study Screening Questionnaire criteria for fibrocriteria. As we do not have a second clinical diagnosis
confirmation, the London-4 criteria were used to ensure
population homogeneity. Although these criteria screen
only for widespread musculoskeletal pain and do not take
into consideration other clinical aspects of FM, they give
an optimal sensitivity (100%) in FM screening population
studies and good positive predictive values for women in
rheumatology settings [35].
A total of 972 questionnaires (43.5%) were returned in
two runs. The eligibility criteria were then applied, and
our selected reference population subsequently consisted
of 920 members with FM (44 did not fit the London-4
criteria and 8 questionnaires did not contain enough
data). The remaining criteria were that the individual
did not walk or the walking pattern did not comply with
one or more features of the selected walking program,
the individual was without comorbidity which impeded
walking or, if there was comorbidity, the individual had
received medical advice to walk. A total of 582 members
(63.3%) satisfied these criteria. Figure 1 is a flowchart of
the participant recruitment process.EFE 5, AFIBROM=3, AFIBROTAR=2; (0.49%) 
EFE 12, AFIBROM=166, AFIBROTAR=18; (8.16%)  




g and comorbidity and no medical recommendation):
) / Not contacted: N = 6 (1.0%)/  
: N = 180 (31.0%) 
NTION GROUP MOTIVATION+ IMPLEMENTATION
INTENTION GROUP 
N=142 
N= 482),  AFIBROM (N= 1555),  AFIBROTAR (N= 332)
FEFE (N= 465),  AFIBROM (N= 1386),  AFIBROTAR (N= 312) 
 AFEFE (N=222),   AFIBROM (N=515),   AFIBROTAR (N= 189)
FE (N=201), AFIBROM (N=489), AFIBROTAR (N=184)
 AFEFE (N= 125), AFIBROM (N= 314), AFIBROTAR (N= 110) 
 AFEFE (N= 106), AFIBROM (N= 220), AFIBROTAR (N= 98)
romyalgia Association of Alicante; AFEFE: Fibromyalgia Association of
gia Association of Talavera de la Reina (Toledo); London-4: London
myalgia.




Assignment, n (%) Total
CG IG MIG
ADEFA 7 (28.0) 9 (36.0) 9 (36.0) 25 (100)
AFEFE 42 (39.6) 29 (27.4) 35 (33.0) 106 (100)
AFIBROM 73 (33.2) 87 (39.5) 60 (27.3) 220 (100)
AFIBROTAR 32 (32.7) 28 (28.6) 38 (38.8) 98 (100)
Total 154 (34.3) 153 (34.1) 142 (31.8) 449 (100)
aADEFA: Fibromyalgia Association of Alicante; AFEFE: Fibromyalgia Association
of Elche; AFIBROM: Fibromyalgia Association of Madrid; AFIBROTAR:
Fibromyalgia Association of Talavera de la Reina (Toledo); CG: Control group;
IG: Implementation intention group; MIG: Motivation and implementation
intention group.
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We calculated the sample size for the experimental
study by taking into consideration the 582 FM parti-
cipants previously identified as the eligible population
derived from the different associations: ADEFA (n = 33,
5.7%), AFEFE (n = 125, 21.5%), AFIBROM (n = 314,
54.0%) and AFIBROTAR (n = 110, 18.9%). The expected
differential increase in the selected exercise prevalence
from baseline is 10% for CG, 20% for IG and 40% for
MIG. Given the rule that the frequency of dropouts
should not exceed the frequency of the effect, we expect
a maximum dropout rate of 30% before random alloca-
tion. This percentage will be added to the calculated
sample size. We have defined the risk α as 5% and the
study power as 80%. The minimum magnitude of the ex-
pected effect (in relation to the effect on CG) is 10% for
IG and 30% for MIG. After we apply these conditions
and dividing the sample population into three experi-
mental groups, each group will consist of 115 persons,
which is equal to 345 participants. In previously reported
supervised programs of moderate-intensity walking, ad-
herence has ranged from 62% [14] to only 37.5% [32]. In
other studies, the percentage of patients who finished
the supervised program was greater than 70% to 80%
[7,15,36-39]. In other words, studies have shown that
more than 20% to 60% of patients do not complete phys-
ical activity programs which include walking. Therefore,
we added a 30% dropout rate as a reasonable calculation,
which gives us a sample size of 449 women with FM.
Randomization
We used a computer program to randomize the three
experimental groups and four fibromyalgia associations,
taking into account the size of each center [40]. The 449
participants were allocated to the three experimental
groups as follows: CG = 154, IG = 153 and MIG = 142
(Table 1). We applied another computer program to
generate random sequences to select the participants
from each fibromyalgia association for the experimental
and control groups [41]. The randomization results will
be checked by analyzing potential confounders such as
walking patterns, physical activity, impact of FM, pain,
emotional status and age (see the “Statistical analysis”
subsection below).
Interventions
In previous studies in the reviewed literature, we found
that interventions for the promotion of walking have
been heterogeneous and that no single method has
proved to be more effective than others [33]. One of the
main advantages of our study is that the intervention is
based on two well-established theories for predicting be-
havior. Following the procedures described in previous
research [42,43], all participants will receive informationabout the benefits of physical exercise in relation to their
FM, and they will be asked to engage in the selected
walking criteria. In addition, MIG participants will re-
ceive motivational interventions, and both the MIG and
IG groups will receive information on the positive effects
of making plans, specifying (1) days, (2) specific times of
day, (3) location (for example, close to work, around the
neighborhood) and (4) duration of the exercise (starting
from the established minimum). Thus, they will be re-
quested to write a specific individualized plan. The esti-
mated duration of the intervention in each group is
90 minutes, conducted in only one group session with a
maximum of 10 people. Figure 2 shows the schedule for
the intervention day.
Motivational intervention
The aim of the motivational intervention is to ensure
strong behavioral intention. The TPB [24] establishes that
the behavioral intention (that is, the readiness to perform
a specific behavior) is determined by the person’s attitude
toward the behavior (the positive or negative global evalu-
ation of performing the specific behavior), the subjective
norm (the social pressure perception of engaging in the
behavior or not) and the perceived behavioral control (the
perception that the behavior is under the person’s control).
Attitudes, subjective norms and perceived behavioral con-
trol are explained, respectively, by behavioral beliefs, nor-
mative beliefs and control beliefs (Figure 3).
In the TPB, beliefs represent the substantive informa-
tion available to guide people’s decisions with regard to
their behavioral performance. Thus, we will target a
modification of participants’ beliefs in order to achieve a
change with regard to the intention. The motivational
intervention will be designed to produce changes in the
behavioral, normative or control beliefs associated with
the predictors of the behavioral intention (stage 2 of
phase I of the research). With regard to the physical ex-
ercise behavior, attitude and control perception have
been found to be the main predictors of the intention to
R1*: General information about the study and the procedure.
Informed consent.  
Evaluation preintervention (baseline)





R2: NEUTRAL Task 1 session
(30 min.)
R4*: IMPLEMENTATION INTENTION session 
(30 min.)
R2: NEUTRAL Task 2 
session (30 min.)
Figure 2 Schedule for the intervention day. *R1 is the researcher who gives general instructions and distributes participants in each session.
R2 is the researcher who gives information about walking to all participants and applies the control intervention. R3 is the researcher who applies
the motivational intervention. R4 is the researcher who applies the implementation intention intervention and is blinded to participants’ previous
experiment condition (motivational or neutral). **MIG: Motivation and implementation intention group; IG: Implementation intention group;
CG: Control group.
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that the relative weight of each predictor (and conse-
quently the targeted beliefs) changes if the specific behav-
ior changes. In fact, with regard to walking, the control
perception has more weight than attitudes [16]. This situ-
ation could differ in people with a chronic health problem
such as FM. Therefore, it is necessary to explore the par-
ticular predictive relationships between the targeted walk-
ing behavior and the specific population [24].
A specific proposal for a brief intervention based on
the TPB for interventions on walking was recently pub-











Figure 3 Schematic illustrating the Theory of Planned Behavior.intervention, such as the identification of the target
constructs, the elicitation of key salient beliefs under-
pinning these constructs and the selection of appropri-
ate behavior change techniques. We followed these
recommendations, and phase I (stage 2) of the study is
focused on the identification of the target constructs
and the salient beliefs through an exploration of the
TPB predictors of walking behavior. The beliefs associ-
ated with these predictors will be used to enhance
intention by implementing writing and imagery tech-
niques. Strategies such as a graded activity will be im-
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intention in the whole group.
Volitive intervention: implementation intentions
Implementation intentions are “if–then” plans that specify
when, where and how a goal will be achieved, linking a
critical situation (the “if” component) with a goal-directed
behavior (the “then” component) [28]. Implementation in-
tentions are hierarchically subordinated to goal intentions
(in this study, the behavioral intention). Implementation
intentions have been shown to have a moderate to strong
effect on goal attainment [46].
We expect participants in the MIG and IG groups to be
able to use their plans to adjust their walking activity to the
circumstances they have foreseen and specified. We will
focus these plans on the management of the inhibitors of
the walking behavior, which we will have previously iden-
tified in stage 2 of phase I (control beliefs). As has been
shown in previous research [47,48], participants can regu-
late their emotional responses through attentional imple-
mentation intentions (for example, to ignore some stimuli)Table 2 Measures taken and schedule during phase Ia
Variables Instrument
Walking behavior
Walking pattern Ad hoc self-report scale
Daily logs
Minutes spent walking in previous week IPAQ walking
Steps and distance Pedometer






Injunctive and descriptive beliefs
Control beliefs
Fear avoidance Spanish adaptation of TSK




Fibromyalgia impact Spanish adaptation of FIQ
Pain intensity 11-points numerical ratin
Emotional status: Distress Spanish adaptation of HA
aFIQ: Fibromyalgia Impact Questionnaire; HADS: Hospital Anxiety and Depression Sc
Behavior; TSK: Tampa Scale for Kinesiophobia. bWomen who attended the associati
were taken at time 1. cFor test–retest reliability.or by specifying their desired behavioral and emotional re-
sponses (for example, to be calm or relaxed). Participants
form their plans individually, and, in order to facilitate the
internalization and memorization of these plans, they will
be requested to write the specific implementation inten-
tions on a sheet of paper and place it in a visible location at
home. A copy of the sheet will be given to the research
team so that the team can perform the follow-up on the
specific goals. This will be the last intervention of the day,
and the researcher who conducts this session will ask par-
ticipants to carry on with the task until they finish.Measures
Phase I (first year)
In the first year of the study, measurements of physical
activity, walking behavior, TPB variables, fear of move-
ment, pain, FM impact and emotional status will be
taken. All questionnaires will be self-administered by the
participants. A summary of variables and schedules in
this phase is shown in Table 2.Scheduleb
Stage 2


















g scale X X
DS X
ale; IPAQ: International Physical Activity Questionnaire; TPB: Theory of Planned
on or university laboratory for assessment. Daily logs and pedometer readings
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we will gather participants’ self-reported information as
outlined below.
1. Spanish version of the International Physical Activity
Questionnaire–Short Form (IPAQ-S) [49]: The IPAQ-S is
an instrument designed to assess physical activity among
adults. It can be used as a tool in intervention studies,
although it was not designed for this purpose. There is a
lack of self-report measures of physical activity designed
for FM patients. In addition, the results obtained from
well-established instruments in general populations are
not good enough in FM patients [50]. However, the
IPAQ-S was previously found to be better than other
physical activity instruments in identifying sedentary pa-
tients with chronic fatigue syndrome [51]. We have
chosen to use the IPAQ-S because of its Spanish transla-
tion; its short form, which is an advantage for our first
mailed survey and for the FM population; and because it
includes walking as a type of physical activity. The
IPAQ-S allows respondents to record their sitting, walk-
ing, moderate-intensity and vigorous activities in mi-
nutes per week and calculate a total physical activity
score. We will use the median minutes per week for
each activity for assessment purposes. The rules for
cleaning and correcting data will be applied [49]. In this
phase, we will use the IPAQ-S to characterize our refer-
ence and study populations.
2. Behaviors: We will use four measures to assess
walking behavior. First, we will use a self-report scale to
assess the usual walking pattern to identify the study
population. The scale consists of six questions designed
to assess whether participants usually walk for physical
exercise, how many minutes they walk daily, how many
days per week they walk, how many consecutive weeks
they walked, whether they took rests during walking and
whether they had been advised to walk by their doctor.
Second, we selected the walking score from the IPAQ-S
[49] because it refers to the previous week of the assess-
ment. It can thus provide a more accurate measurement
than our general measures because of its proximity in time
and because it can limit the influence of the participant’s
memory.
Third, we have designed weekly and daily logs to as-
sess walking behavior over the course of 6 consecutive
weeks. Daily logs include the days and minutes of walk-
ing and the duration of rest during the activity. In
addition, participants score the perceived intensity of the
activity using the Borg Rating of Perceived Exertion scale
[52]. Participants will use a pedometer (3D USB Pedom-
eter PDM-2608) to record the number of steps and dis-
tance covered over the same period.
These measures will be used to explore the agreement
between subjective and objective measurements. We
need to establish this agreement because the entire studypopulation will use daily logs, but only half of them will
use pedometers.
Motivational variables To assess for motivational vari-
ables, we will gather participants’ self-reported informa-
tion as outlined below.
1. TPB variables: Behavioral intentions, attitudes
toward behaviors, perceived norms, perceived
behavioral control, behavioral beliefs, normative
beliefs and control beliefs will be measured
according to the TPB recommendations [24]. The
questionnaire was tested in a previous study and
showed good psychometric properties (MAP, SLR,
YS, CP, LV, MC, AL and CE, unpublished
manuscript). These measures will allow us to
identify the predictors of behavioral intentions and
consequently to modify or strengthen the beliefs
upon which they are based during the motivational
interventions.
2. Fear of movement: We will use the total score on
the Spanish adaptation of the Tampa Scale for
Kinesiophobia to measure fear of movement [53].
Patients will rate 11 items on a four-point Likert
scale (from 1 = totally disagree to 4 = totally agree).
This measure will allow us to explore the role of fear
of movement in relation to behavioral intentions.
Health status variables To assess for health status vari-
ables, we will gather participants’ self-reported informa-
tion as outlined below.
1. Pain: We will use the total score on an 11-point
numerical rating scale (from 0 = “no pain at all” to
10 = “the worst pain you can imagine”) adapted
from Jensen et al. [54] to assess the maximum,
minimum and usual pain intensity during the week
prior to the evaluation and the pain intensity that
moment. The scale has shown good psychometric
properties in Spanish FM samples [55,56].
2. FM impact: We will use the total score of the
consensus version of the Spanish adaptation of the
Fibromyalgia Impact Questionnaire (FIQ), which is
valid and reliable [57].
3. Emotional status: The perceived total distress is
measured with the Spanish adaptation [58] of the
Hospital Anxiety and Depression Scale [59]. Patients
rate 14 items on a four-point answer scale. This
scale has been shown to be valid and reliable [58].
Our aim in assessing these variables is, on the one
hand, to explore their role in behavioral intention and,
on the other hand, to explore them as potential
confounders.
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A summary of variables and the schedule of phase II is
given in Table 3.Primary outcome measures
Two primary outcomes will be assessed as indicators of
each intervention’s effect on exercise adherence:
1. We will measure the proportion of participants who
perform the full minimum walking criteria (at least
30 minutes in bouts of 15 minutes with a small rest
between bouts, twice times weekly over a minimum
of 6 consecutive weeks) at the end of the 6-week
period and the proportion of participants who have
maintained it at 3 and 9 months. The expected
efficacy of MIG is 30% higher than CG and 10%
higher than IG.
2. Among participants who perform the full minimum
walking criteria, we will focus on the proportion who
reach the recommended pattern for FM patients at
week 6 (between two and four times weekly for about
50 minutes in bouts of 15 to 20 minutes over a
minimum of 6 consecutive weeks) [31].
We will use the same self-reported measurements of
the behavior from phase I (ad hoc self-reported items




Walking pattern Ad hoc self-report scale X
Daily logs
Steps and distance Pedometerb
Secondary
Total physical activity IPAQ X
Intense physical activity X
Moderate physical activity X
Walking X
Sitting X
Physical function Six-Minute Walk Test X
FM Impact FIQ X
Pain intensity Ad hoc scale X
Emotional status: Distress HADS X
Mediators
Behavioral intentionc TPB items X
Implementation intentionsc Ad hoc items
aFIQ: Fibromyalgia Impact Questionnaire; HADS: Hospital Anxiety and Depression Sc
Behavior. bLimit of recording is 60 days. cAlso measured at the end of the interventSecondary outcome measures
Six-Minute Walk Test (6MWT): The 6MWT is a clinic-
ally relevant measure of the physical function that the
Spanish Society of Rheumatology recommends using
with FM patients [60].
The remaining secondary measures are described in
the measures of phase I: IPAQ-S score [49], FIQ score
[57], pain intensity rating [55] and emotional status [58].
Mediators
1. Behavioral intentions: In a previous study, we
designed and proved the high internal consistency
(α = 0.87) of five items for an ad hoc questionnaire
(MAP, SLR, YS, CP, LV, MC, AL and CE,
unpublished manuscript). These items are used to
assess the individual’s readiness to carry out the full
walking pattern: “I intend to walk,” “I will walk,” “I
am willing to walk,” “I plan to walk” and “I will make
an effort to walk at least 30 minutes in bouts of
15 minutes, with a small rest between bouts, twice
weekly for a minimum of 6 consecutive weeks.” All
answers given are scored according to a numerical
rating scale from 1 to 7.
2. Implementation intentions: A postexperiment
questionnaire will be used to assess how committed
patients felt toward meeting their goals (“How
committed did you feel to the self-regulationSchedule















ale; IPAQ: International Physical Activity Questionnaire; TPB: Theory of Planned
ion sessions.
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your self-regulation intentions?”) and their perceived
performance (“How difficult was it to achieve your
walking behavior?” “Did your self-regulation intention
help you achieve the proposed walking behavior?”
and “How well did you succeed in realizing your
self-regulation intention?”). All of these items will be
accompanied by 11-point answer scales ranging from
0 (“not at all”) to 10 (“very”).
Statistical analysis
Data will be entered into a relational database system
(Microsoft Access; Microsoft, Redmond, WA, USA) with
range rules and forms, which will reduce the number of
data entry mistakes. In addition, we will apply a program
to check and clean data [61]. Analyses will be made
using the IBM SPSS Statistics 21 software packageTable 4 Descriptive statistics in eligible and noneligible popu
Variables Noneligible
Mean (95% CI) SD Median
Age (years) 53.51 (52.59 to 54.42) 8.52 54.24
Pain intensity 6.63 (6.43 to 6.83) 1.82 6.62
Fatigue 8.01 (7.79 to 8.23) 2.01 8.00
Fatigue upon waking 7.99 (7.74 to 8.25) 2.37 9.00
Fatigue impact perception 6.78 (6.48 to 7.08) 2.77 7.00
Cognitive problems 6.77 (6.48 to 7.05) 2.62 7.00
Sleeping disorder impact perception 7.07 (6.75 to 7.38) 2.94 8.00
Cognitive problems impact
perception
6.30 (6.00 to 6.61) 2.83 7.00
IPAQ-Sitting, mi/wk 240.5
IPAQ-Walking, min/wk 300.5
IPAQ-Moderate activities, min/wk 0.5
IPAQ-Vigorous activities, min/wk 0.5











Retired (pain) 39 (11.6)
Sick leave 32 (9.6)
Housewife 87 (26.0)
aCI: Confidence interval; IPAQ: International Physical Activity Questionnaire; SD: Stan(SPSS, Chicago, IL, USA) and LISREL software (SSI
Scientific Software International, Skokie, IL, USA).Phase I
Descriptive analyses have been performed. The sociodemo-
graphic characteristics, symptoms, walking and physical
activity of eligible and noneligible populations have been
compared by conducting χ2 tests, t-tests, analysis of vari-
ance and median nonparametric tests, depending on the
characteristics of the variables (Table 4). These compari-
sons were conducted to ensure that both samples differ
only with regard to the inclusion criteria of the study. The
same analyses were performed to compare participants
with individuals who refused to participate and nonre-
sponders (that is, not contacted or not available at the time
of measurement) (Table 5).lationsa
Eligible




6.73 (6.59 to 6.87) 1.70 6.75
8.20 (8.36 to 8.39) 1.96 9.00
8.17 (8.00 to 8.25) 2.20 9.00
7.01 (6.78 to 7.23) 2.72 7.00
7.00 (6.78 to 7.21) 2.66 8.00
7.02 (6.70 to 7.26) 2.95 8.00
6.57 (6.34 to 6.80) 2.83 7.00
(240.5 to 300.5) 300.5 (240.5 to 300.5)
(245.5 to 350.5) 180.5 (140.5 to 180.5)
(0.5 to 60.5) 0.5 (0.5 to 0.5)
(0.5 to 0.5) 0.5 (0.5 to 0.5)













Table 5 Descriptive statistics in participants and nonparticipants from eligible populationa
Variables Nonparticipant group Participant group
Mean (95% CI) SD Median (95% CI) Mean (95% CI) SD Median (95% CI)
Age (years) 52.41 (51.42 to
53.40)
8.79 53.17 51.84 (50.75 to
52.93)
9.16 52.69
Pain intensity 6.76 (6.56 to 6.95) 1.72 6.75 6.70 (6.50 to 6.90) 1.67 6.50
Fatigue 8.19 (7.96 to 8.42) 2.02 9.00 8.22 (7.99 to 8.44) 1.90 9.00
Fatigue upon waking 8.24 (7.99 to 8.49) 2.22 9.00 8.10 (7.84 to 8.36) 2.17 9.00
Fatigue impact perception 7.05 (6.76 to 7.34) 2.60 8.00 6.96 (6.62 to 7.29) 2.85 7.00
Cognitive problems 6.92 (6.62 to 7.22) 2.69 7.00 7.08 (6.77 to 7.39) 2.63 8.00
Sleep disorder impact perception 7.01 (6.66 to 7.35) 3.07 8.00 7.03 (6.70 to 7.37) 2.82 8.00
Cognitive problems impact
perception
6.46 (6.14 to 6.79) 2.86 7.00 6.68 (6.35 to 7.02) 2.79 7.00








IPAQ-Moderate activities, min/wk 0.5 (0.5 to 0.5) 0.5 (0.5 to 15.5)
IPAQ-Vigorous activities, min/wk 0.5 (0.5 to 0.5) 0.5 (0.5 to 0.5)




n (%) n (%)
Education level
Literate 32 (10.4) 35 (12.8)
Primary 132 (42.9) 129 (47.1)
Secondary 86 (27.9) 77 (28.1)
University 58 (18.8) 33 (12)
Employment status
Working 92 (30.4) 85 (31.1)
Unemployed 59 (18.9) 59 (21.6)
Retired 25 (8.1) 13 (4.8)
Retired (pain) 32 (10.4) 27 (9.9)
Sick leave 32 (10.4) 18 (6.6)
Housewife 67 (21.8) 71 (26.0)
aCI: Confidence interval; IPAQ: International Physical Activity Questionnaire; SD: Standard deviation.
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ligible population (n = 338) and the eligible population
(n = 582) regarding the distribution of the patients drawn
from the different FM associations (χ2 = 2,670, P = 0.445,
df = 3. With regard to sociodemographic variables, we
found significant differences only for age between the eli-
gible and the noneligible populations (t = 2.264, P = 0.024,
df = 914, mean difference = 1.37, 95% CI = 0.18 to 2.55).
This difference was not found, however, when we consid-
ered the FM associations in the analysis (eligible group by
FM association: F = 1.928, P = 0.124; noneligible group by
FM association: F = 2.403, P = 0.067). No significant differ-
ences were found between groups for either education
level (χ2 = 1.810, P = 0.613, df = 3) or employment status
(χ2 = 5.912, P = 0.436, df = 6). Groups were also similar inpain intensity perception (t = −0.833, P = 0.415, df = 913),
fatigue (t = −1.38, P = 0.167, df = 909), fatigue upon waking
(t = −1.16, P = 0.245, df = 910), impact perception of fa-
tigue (t = −1.21, P = 0.226, df = 909), cognitive problems
(t = −1.27, P = 0.205, df = 910), impact perception of cogni-
tive problems (t = −1.37, P = 0.173, df = 908) and impact
perception of sleeping disorders (t = 0.25, P = 0.806, df =
911). The last six variables were included in the mailed
questionnaire to identify the study population. All of them
were calculated for the previous week and were measured
using an 11-point numerical rating scale (from 0 = nothing
at all to 10 = totally). In relation to IPAQ-S variables, me-
dian total activity, walking and moderate-intensity ac-
tivities were different (P ≤ 0.01) and similar in vigorous
activities (P = 0.296) and sitting (P = 0.442) (Table 4).
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cause of the difficulties involved in the participation of
the first 449 selected women, such as the failure to con-
tact them after repeated attempts, nonattendance after
three citations and distance of residence from the study
location. Ultimately, 274 patients accepted and attended
the first evaluation session (participation rate = 47.1%).
No significant differences were found between these 274
participants and women with FM who did not partici-
pate in this phase of the study (n = 308) on the basis of
any of the above-mentioned variables (age: t = 0.767, P =
0.443, df = 579; education level: χ2 = 5.567, P = 0.135;
df = 3; employment status: χ2 = 7.567, P = 0.272, df = 6;
pain intensity perception: t = 0.389, P = 0.697, df = 579;
fatigue: t = −0.178; P = 0.858, df = 576; fatigue upon wak-
ing: t = 0.785, P = 0.433, df = 576; impact perception of
fatigue: t = 0.410, P = 0.410, df = 577; cognitive problems:
t = −0.718, P = 0.473, df = 577; impact perception of cog-
nitive problems: t = −0.939, P = 0.348, df = 577; impact
perception of sleeping disorders: t = −0.107, P = 0.915,
df = 577). The groups showed different medians of mod-
erate activities (P ≤ 0.01), but similar medians in total ac-
tivity (P = 0.066), sitting (P = 0.208), walking (P = 0.609)
and vigorous activities (P = 0.115). In addition, the groups
presented a proportion of noncompliance similar to that
of the total unsupervised pattern (45.8% and 44.2%, re-
spectively) and the same proportion reported for medical
recommendation to walk (81.8% in each group) (Table 5).
Internal consistency analysis will be performed for the
different scales using the Cronbach’s α coefficient. Path
analysis will be conducted to identify the relative weights
of attitudes, perceived norms and perceived behavioral
control in the prediction of the behavioral intention
(path coefficients). Furthermore, we will test the role of
the fear of movement, pain and FM impact. Spearman
and Pearson correlations and cross-tabulation analysis
(depending on the variables) will be used to explore the
agreement of the behavioral measurements.
Phase II (second and third years)
As our main outcome is a binary variable, backward
stepwise logistic regression analysis will be applied. This
method will allow us to investigate whether the experi-
mental condition is associated with the acquisition of
the walking pattern. Analysis will be performed for each
time measure. Changes in walking behavior over time
will be analyzed by applying a Cox proportional hazards
regression model for recurrent events. Using this meth-
odology, we will estimate the hazard function of the out-
come measure (the likelihood of walking over time). We
will analyze differences between groups by introducing
the experimental condition as a predictor of the moment
in the longitudinal study when women maintained the
walking pattern.Randomization results will be checked to ensure that
groups are comparable at the beginning of the study in
terms of their distribution of potential confounding factors
(walking pattern, IPAQ, FIQ, pain, age, emotional status
and behavioral intention). The potential confounders will
be selected according to previous analyses at baseline by
applying confusion criteria (associations with exposition:
P ≤ 0.20 and correlation coefficients >0.10; associations
with the main result in CG: OR < 0.67 or OR > 1.5). Statis-
tical adjustment to control for the impact of confounders
on effect estimation will be applied by introducing them
into the analyses (if changes in OR are greater than 10%).
Effect modifiers of basal walking pattern will also be
tested.
Multiple regression analysis will be performed for each
secondary outcome variable. Baseline data will be intro-
duced in the predictive model for each time measure.
We will test the mediating effects of the behavioral
intention and of implementation intentions in the total
sample using path analysis.
Discussion
The benefits of physical activity associated with FM pa-
tients’ health status are well established. Exercise programs
have been applied in isolation or together with other inter-
ventions in multidisciplinary treatments. There is evidence
of clinical benefits of aerobic exercise for FM patients [3].
Most exercise programs are supervised in professional
contexts, but the reported adherence to these programs is
not encouraging [8-12]. Walking represents a similar prob-
lem. Although some authors have reported satisfactory
compliance rates for walking [14], the exercise was per-
formed in specific conditions, with walking poles and in
group sessions with a monitor, which might contribute to
an increase in adherence.
Walking is recommended to people with FM [4] and to
adults in general [62]. It is easily accessible, cheap and
popular, and it helps promote self-regulation and self-
efficacy [10]. Our study will endorse these features because,
although unsupervised, participants will be expected to
walk for a minimum time under specific conditions. This
minimum is easily reached by sedentary FM participants,
and each participant can increase it gradually (at least up
to the recommended pattern for FM patients [31]) or
maintain the minimum level established in the study. In
fact, because our intervention promotes participants’ self-
regulation, we also expect that they will set their own goals,
which may include longer walking times. In addition, the
study will allow us to test whether different basal walking
patterns have differential benefits by analyzing the effect
modifier of the relationship between experimental condi-
tions and main results. For example, the effect of interven-
tions might be higher in participants who do not walk at
all than in participants who do.
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address adherence to unsupervised walking patterns of
FM patients by combining motivational and volitional
strategies with strong theoretical foundations in health
psychology. This combination has shown good results in
the general population [16,18,19], but to our knowledge
it has not been used in FM patients.
TPB is the selected theoretical model for the design of
the motivational intervention. It has allowed us to identify
the modal salient beliefs (behavioral, normative and con-
trol) in a previous elicitation study with a sample of the
study population (MAP, SLR, YS, CP, LV, MC, AL and CE,
unpublished manuscript). As soon as the predictors of the
behavioral intention are assessed in phase I, we will address
the specific beliefs of FM participants, which should be
modified or strengthened in the motivational intervention.
By adding to these intervention implementation intentions,
we expect to enhance the selected walking behaviors and
to raise adherence. Both strategies have been recom-
mended elsewhere [5]. Furthermore, using implementation
intentions encourages each participant to carry out their
own action plans (based on the established minimum), tak-
ing into account their personal circumstances.
The initial data have allowed us to identify the charac-
teristics of the study population. In addition, the prelim-
inary results have shown differences between members
of the FM population who meet the inclusion criteria in
this study (eligible population) and those who do not
(noneligible) in total, moderate and walking activities.
These results support the appropriateness of these cri-
teria with regard to walking patterns. The activities and
demographic characteristics of the participants who re-
fused to participate, as well as the nonresponders from
the eligible population, were similar to those of the par-
ticipants. Although participants were different in regard
to moderate intensity activities, the median values were
the same and only a slightly higher percentage of FM
participants took part in moderate activity as compared
to nonparticipants. These results also support the repre-
sentativeness of the study sample. We are aware of the
difficulties of the research because the targeted popula-
tion is sedentary. However, the effect of exercise inter-
ventions has been substantial in this type of patient.
The study has some limitations, which are mainly re-
lated to the voluntary participation of the FM partici-
pants from the several FM associations. First, we should
mention the selection bias. It is possible that these par-
ticipants were more active than other FM patients who
do not belong to an association. This fact could influ-
ence both their physical activity and their motivation to
exercise, and it could limit the effect of the intervention
on walking behavior. However, this problem can be cor-
rected by the possible variability in the behavioral inten-
tions and the selected target population, who are allsedentary people. Furthermore, in Spain, the majority of
FM patients belong to an association because their treat-
ment needs are not covered by the public health system.
Joining a FM patient association substantially decreases
the expenses related to the illness [63]. Therefore, the
variability of the members might be considered similar
to the variability of people with FM.
Second, the recruitment of participants from among
members of FM associations does not allow us to moni-
tor the diagnostic criteria. The clinical confirmation of
the FM diagnosis is not part of our study protocol. How-
ever, American College of Rheumatology criteria [64]
have been widely used by Spanish physicians, because
they are the criteria for FM diagnosis recommended by
the Spanish Ministry of Health [65,66] and the Spanish
Society of Rheumatology [60]. Moreover, a screening
questionnaire [34] was introduced into the study as an
inclusion criterion.
Third, we do not know the participants’ level of educa-
tion regarding exercise in FM. However, they will receive
the same information about the benefits of physical ex-
ercise and walking, specifically as a component of the
intervention.
Fourth, the primary tool we will use to assess physical
activity habits has not been validated in FM, but our
interest is focused on the performance of a specific walk-
ing pattern, which is not measured by standard ques-
tionnaires. The IPAQ results will be used mainly to
support our population selection based on self-reported
walking behavior.
It is important to underline that as soon as the final
274 participants agree to participate, strategies to avoid
having participants dropping out will be implemented.
In that sense, we will contact the 180 women who failed
to attend the evaluation session but did not refuse to
participate in the study. Because the participants belong
to FM associations which conduct other activities for
their members, we may have problems with the masking
process. Participants might talk among themselves about
the activities performed in each intervention group.
However, nobody knows which intervention group is ex-
pected to be more successful. Participants will sign a
commitment of confidentiality, and, furthermore, we will
also assess the shaping of implementation intentions in
the control group.
In spite of these limitations, the study addresses an im-
portant need: the enhancement of self-management in the
treatment of FM. It focuses on increasing adherence to a
strategy which has been shown to be effective (physical ex-
ercise, specifically walking). Furthermore, the results are
expected to show the effectiveness of a short intervention
which is easily applicable with a minimum of training and
cost and that can be incorporated into routine clinical
practice.
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Enrollment into the study started in May 2012. The ex-
perimental study are expected to be completed by the
end of June 2014.
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